Jan 13 (Reuters) -
Johnson & Johnson:
* JOHNSON & JOHNSON STRENGTHENS NEUROSCIENCE LEADERSHIP WITH
ACQUISITION OF INTRA-CELLULAR THERAPIES, INC.
* JOHNSON & JOHNSON ( JNJ ) - DEAL VALUED AT $14.6 BILLION, $132 PER
SHARE
Source text:
Further company coverage: